Stock search

Ticker or company name

Compare stocks

Market: US

  • CRLCharles River Laboratories
  • RVTYRevvity
  • TECHBio-Techne

Add stock

Ticker or company

Summary

CRL
Charles River Laboratories
$335,52Down −0,72%
Year: Up +100%
50/100Ratio would watch
Open stock page
RVTY
Revvity
$148,85Down −3,59%
Year: Up +65%
56/100Ratio would watch
Open stock page
TECH
Bio-Techne
$72,79Down −0,01%
Year: Up +20%
69/100Best scoreRatio would watch
Open stock page

Verdict

TECH has the best score (69). RVTY grows revenue the fastest. RVTY is the cheapest by forward P/E. TECH has the lowest debt load. TECH has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckCRL4 ✓ 1 — 4 ✕RVTY4 ✓ 2 — 3 ✕TECH4 ✓ 3 — 1 ✕
P/E vs its history403,068,162,9
P/E vs industry403,068,162,9
Forward P/E29,527,134,2
Revenue growth, YoY−1,2%+4,6%+0,9%
EPS growth, YoY—+13,1%+122,4%
Net margin1,1%8,6%n/a—
Net debt / EBITDA−0,52,6−1,0
Free cash flow$400 m$590 m$308 m
Share count over a year−1,7%−3,1%+1,0%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterCRLTTMRVTYTTMTECHTTMIndustry medianTTM
P/E TTM ↓Worst: 403,068,1Best: 62,937,9
Forward P/E ↓29,5Best: 27,1Worst: 34,229,5
PEG ↓n/aBest: 8,0Worst: 9,83,7
P/S TTM ↓Best: 4,15,9Worst: 9,46,6
EV/EBITDA ↓Worst: 82,1Best: 25,832,629,9
P/FCF ↓39,1Best: 29,2Worst: 43,438,7

Price, %

  • CRLn/a
  • RVTYn/a
  • TECHn/a

Returns

Best WorstNo mark — in between

PeriodCRLRVTYTECH
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

CRLRVTYTECH
Share of “buy”Best: 77%44%Worst: 0%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 1 of 4
Average “surprise”+4,5%Best: +6,7%Worst: −0,8%
Insiders over 12 monthssales $52,1 msales $5,97 msales $437 178

Details are on each stock page.